期刊
AMERICAN JOURNAL OF PUBLIC HEALTH
卷 101, 期 12, 页码 2217-2222出版社
AMER PUBLIC HEALTH ASSOC INC
DOI: 10.2105/AJPH.2011.300279
关键词
-
资金
- U.S. National Institutes of Health, National Cancer Institute [5R21CA131880]
Although extensive research addresses minorities' low participation in clinical research, most focuses almost exclusively on therapeutic trials. The existing literature might mask important issues concerning minorities' participation in clinical trials, and minorities might actually be overrepresented in phase I safety studies that require the participation of healthy volunteers. It is critical to consider the entire spectrum of clinical research when discussing the participation of disenfranchised groups; the literature on minorities' distrust, poor access, and other barriers to trial participation needs re-examination. Minority participation in clinical trials is an important topic in public health discussions because this representation touches on issues of equality and the elimination of disparities, which are core values of the field. (Am J Public Health. 2011;101: 2217-2222. doi:10.2105/AJPH.2011.300279)
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据